Higher Income Tied to Withdrawal of Life-Sustaining Therapies
By Lori Solomon HealthDay Reporter
WEDNESDAY, Jan. 24, 2024 -- Living in a high-income ZIP code increases the likelihood of withdrawal of life-sustaining therapies (WLSTs) for people with intracerebral hemorrhage (ICH), according to a study published online Jan. 18 in Neurology.
Kara R. Melmed, M.D., from NYU Langone Health in New York City, and colleagues examined differences in WLSTs and mortality in patients with ICH by neighborhood socioeconomic status. The analysis included retrospective data from 868 patients treated for ICH at one of three tertiary care hospitals from January 2017 to December 2022.
The researchers found that patients from ZIP codes with higher median household incomes had a higher incidence of WLST and mortality. There also was a significant association between Black non-Hispanic race and lower WLST and discharge mortality. When adjusting for age and clinical severity scores, patients who lived in ZIP codes with high income levels were more likely to have WLST (adjusted odds ratio, 1.88) and mortality before discharge (adjusted odds ratio, 1.5).
"Clinicians in future may need to tailor end-of-life care discussions, taking into account cultural and social factors when treating patients who have suffered an intracerebral hemorrhage and, in particular, with respect to withdrawing life support," senior author Jennifer A. Frontera, M.D., also from NYU Langone Health, said in a statement.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted January 2024
Read this next
Considerable Disparities in Life Expectancy Exist Within U.S. Population
FRIDAY, Nov. 22, 2024 -- There are considerable differences in life expectancy between different groups within the U.S. population, according to a study published online Nov. 21...
COVID-19 Mortality Higher for Leukemia, Myelodysplastic Syndrome Patients
THURSDAY, Nov. 21, 2024 -- The risk for COVID-19 hospitalization is low in adults with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), but these individuals have...
AI Model FastGlioma Can Detect Glioma Infiltration During Surgery
THURSDAY, Nov. 21, 2024 -- The artificial intelligence (AI) model FastGlioma can detect glioma infiltration during surgery, according to a study published online Nov. 13 in...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.